Latest filingSep 02, 2026Most recent Form 4
SPRY
ARS Pharmaceuticals, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$01 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period1transactions
- A · Grants / awards · dominant1 · 100%
Activity by reported role
A joint filing can contribute to multiple roles1transactions
- CCO · dominant1 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSmith Margaret EkinsStock Option (right to buy) · Direct
1,001,738Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- SE+$0
Recent filing activity
Most recent 1 transactions · color = transaction code- AGrant09/02$0SEC
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
SPRY transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| SPRY | Smith Margaret Ekins | CCO | grant | 1.00M | $0 | A | — | 0.0% | 09/02 | 09/01 |
ARS Pharmaceuticals, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at ARS Pharmaceuticals, Inc.?
Smith Margaret Ekins.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.